Skip Nav Destination
Current Studies in Hematology and Blood Transfusion
International Society of Blood Transfusion: 7th Congress, Rome, September 1958: ProceedingsAvailable to Purchase
Edited by
S.Karger AG
Volume
10
Status:
Available
ISBN electronic:
978-3-318-03472-1
ISBN print:
978-3-8055-0105-7
Discontinued Book Series:
Current Studies in Hematology and Blood Transfusion
Subject Area:
Hematology
Publication date:
1959
Chapter Contents
Book Chapter
814a - 814a: Rationale for a Plasma Fractionation Programme for the Preparation of Clinically Adequate Products Free
By
V. Grifols
V. Grifols
Barcelona, Spain
Search for other works by this author on:
-
Published:1959
-
Discontinued Book Series: Current Studies in Hematology and Blood TransfusionSubject Area: Hematology
Citation
J. A. Grifols, W. E. Böttcher, V. Grifols, 1959. "Rationale for a Plasma Fractionation Programme for the Preparation of Clinically Adequate Products", International Society of Blood Transfusion: 7th Congress, Rome, September 1958: Proceedings, L.P. Holländer
Download citation file:
© Copyright 1959 by S. Karger AG
1959
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
Abstract
Three years' experience with the manufacture of PPL (a pasteurized plasma protein solution) and over one year's experience of plasma fractioning by the Nitschmann modification of the method of Cohn have led us to develop a number of own ideas concerning the approach to the whole fractionation programme as regards products, methods and clinical use and which are described in detail.
